George Sellers
Stock Analyst at Stephens & Co.
(1.05)
# 3,870
Out of 5,090 analysts
43
Total ratings
27.27%
Success rate
-7.09%
Average return
Main Sectors:
Stocks Rated by George Sellers
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ESTA Establishment Labs Holdings | Reiterates: Overweight | $68 | $70.79 | -3.94% | 7 | Aug 7, 2024 | |
| TFX Teleflex | Maintains: Overweight | $275 → $290 | $120.50 | +140.66% | 9 | Aug 2, 2024 | |
| VCEL Vericel | Maintains: Overweight | $56 → $58 | $36.23 | +60.09% | 2 | Aug 2, 2024 | |
| TMDX TransMedics Group | Maintains: Overweight | $151 → $178 | $136.51 | +30.39% | 2 | Aug 2, 2024 | |
| ANIK Anika Therapeutics | Reiterates: Equal-Weight | $24 | $9.60 | +150.00% | 6 | May 29, 2024 | |
| ENOV Enovis | Initiates: Overweight | $72 | $27.02 | +166.47% | 1 | Feb 13, 2024 | |
| APYX Apyx Medical | Maintains: Overweight | $8 → $5 | $3.94 | +26.90% | 2 | Nov 10, 2023 | |
| TMCI Treace Medical Concepts | Reiterates: Equal-Weight | $25 | $2.74 | +812.41% | 4 | Sep 12, 2023 | |
| STAA STAAR Surgical Company | Reiterates: Overweight | $57 | $25.38 | +124.59% | 6 | Aug 14, 2023 | |
| GKOS Glaukos | Reiterates: Overweight | $71 | $108.51 | -34.57% | 4 | May 8, 2023 |
Establishment Labs Holdings
Aug 7, 2024
Reiterates: Overweight
Price Target: $68
Current: $70.79
Upside: -3.94%
Teleflex
Aug 2, 2024
Maintains: Overweight
Price Target: $275 → $290
Current: $120.50
Upside: +140.66%
Vericel
Aug 2, 2024
Maintains: Overweight
Price Target: $56 → $58
Current: $36.23
Upside: +60.09%
TransMedics Group
Aug 2, 2024
Maintains: Overweight
Price Target: $151 → $178
Current: $136.51
Upside: +30.39%
Anika Therapeutics
May 29, 2024
Reiterates: Equal-Weight
Price Target: $24
Current: $9.60
Upside: +150.00%
Enovis
Feb 13, 2024
Initiates: Overweight
Price Target: $72
Current: $27.02
Upside: +166.47%
Apyx Medical
Nov 10, 2023
Maintains: Overweight
Price Target: $8 → $5
Current: $3.94
Upside: +26.90%
Treace Medical Concepts
Sep 12, 2023
Reiterates: Equal-Weight
Price Target: $25
Current: $2.74
Upside: +812.41%
STAAR Surgical Company
Aug 14, 2023
Reiterates: Overweight
Price Target: $57
Current: $25.38
Upside: +124.59%
Glaukos
May 8, 2023
Reiterates: Overweight
Price Target: $71
Current: $108.51
Upside: -34.57%